{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:54:02Z","timestamp":1790639642159,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601253"],"award-info":[{"award-number":["81601253"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81820108016"],"award-info":[{"award-number":["81820108016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key R&D Program of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ovarian hyperstimulation syndrome (OHSS) is one of the most life-threatening and potentially fatal complications associated with controlled ovarian hyperstimulation (COH) during in vitro fertilization (IVF) treatment. Although the pathogenesis of OHSS remains unclear, elevated serum estradiol (E2) levels before human chorionic gonadotropin (hCG) administration are associated with the risk of OHSS. The pineal hormone melatonin and its receptors are expressed in human granulosa cells and have been shown to stimulate E2 production. However, the effect of melatonin on the expression of aromatase, an enzyme responsible for a key step in the biosynthesis of E2, in human granulosa cells remains to be determined. Here, we demonstrate that melatonin upregulates aromatase expression in primary cultured human granulosa-lutein (hGL) cells through the melatonin receptor-mediated PKA-CREB pathway. Using a mouse model of OHSS, we demonstrate that administration of the melatonin receptor inhibitor luzindole inhibits the development of OHSS. In addition, the expression of ovarian aromatase and serum E2 levels are upregulated in OHSS mice compared to control mice, but this upregulation is attenuated by inhibition of the function of melatonin. Moreover, clinical results reveal that aromatase expression levels are upregulated in hGL cells from OHSS patients. Melatonin and E2 levels in the follicular fluid are significantly higher in OHSS patients than in non-OHSS patients. Furthermore, melatonin levels are positively correlated with E2 levels in follicular fluid. This study helps to elucidate the mechanisms mediating the expression of aromatase in hGL cells and provides a potential mechanism explaining the high E2 levels in patients with OHSS.<\/jats:p>","DOI":"10.1038\/s12276-020-00491-w","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T06:04:31Z","timestamp":1598508271000},"page":"1341-1350","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Melatonin stimulates aromatase expression and estradiol production in human granulosa-lutein cells: relevance for high serum estradiol levels in patients with ovarian hyperstimulation syndrome"],"prefix":"10.1038","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5399-9327","authenticated-orcid":false,"given":"Jung-Chien","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongqiong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Pu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"key":"491_CR1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1055\/s-2004-823024","volume":"22","author":"ER Simpson","year":"2004","unstructured":"Simpson, E. R. Models of aromatase insufficiency. Semin. Reprod. Med. 22, 25\u201330 (2004).","journal-title":"Semin. Reprod. Med."},{"key":"491_CR2","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1210\/jcem-70-4-1041","volume":"70","author":"KJ Doody","year":"1990","unstructured":"Doody, K. J., Lorence, M. C., Mason, J. I. & Simpson, E. R. Expression of messenger ribonucleic acid species encoding steroidogenic enzymes in human follicles and corpora lutea throughout the menstrual cycle. J. Clin. Endocrinol. Metab. 70, 1041\u20131045 (1990).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.steroids.2008.01.017","volume":"73","author":"C Stocco","year":"2008","unstructured":"Stocco, C. Aromatase expression in the ovary: hormonal and molecular regulation. Steroids 73, 473\u2013487 (2008).","journal-title":"Steroids"},{"key":"491_CR4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","volume":"8","author":"A Delvigne","year":"2002","unstructured":"Delvigne, A. & Rozenberg, S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum. Reprod. Update 8, 559\u2013577 (2002).","journal-title":"Hum. Reprod. Update"},{"key":"491_CR5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/0974-1208.86080","volume":"4","author":"P Kumar","year":"2011","unstructured":"Kumar, P., Sait, S. F., Sharma, A. & Kumar, M. Ovarian hyperstimulation syndrome. J. Hum. Reprod. Sci. 4, 70\u201375 (2011).","journal-title":"J. Hum. Reprod. Sci."},{"key":"491_CR6","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Electronic address, A.a.o. & Practice Committee of the American Society for Reproductive, M. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil. Steril. 106, 1634\u20131647 (2016)."},{"key":"491_CR7","first-page":"160","volume":"23","author":"TH Lee","year":"2008","unstructured":"Lee, T. H. et al. Serum anti-Mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum. Reprod. 23, 160\u2013167 (2008).","journal-title":"Hum. Reprod."},{"key":"491_CR8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/B:JARG.0000027016.65749.ad","volume":"21","author":"DJ Hendriks","year":"2004","unstructured":"Hendriks, D. J. et al. Use of stimulated serum estradiol measurements for the prediction of hyperresponse to ovarian stimulation in in vitro fertilization (IVF). J. Assist. Reprod. Genet. 21, 65\u201372 (2004).","journal-title":"J. Assist. Reprod. Genet."},{"key":"491_CR9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-079X.1993.tb00517.x","volume":"15","author":"A Cavallo","year":"1993","unstructured":"Cavallo, A. Melatonin and human puberty: current perspectives. J. Pineal Res. 15, 115\u2013121 (1993).","journal-title":"J. Pineal Res."},{"key":"491_CR10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1600-079X.1996.tb00287.x","volume":"21","author":"A Cagnacci","year":"1996","unstructured":"Cagnacci, A. Melatonin in relation to physiology in adult humans. J. Pineal Res. 21, 200\u2013213 (1996).","journal-title":"J. Pineal Res."},{"key":"491_CR11","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1007\/s00018-014-1579-2","volume":"71","author":"D Acuna-Castroviejo","year":"2014","unstructured":"Acuna-Castroviejo, D. et al. Extrapineal melatonin: sources, regulation, and potential functions. Cell. Mol. life Sci. 71, 2997\u20133025 (2014).","journal-title":"Cell. Mol. life Sci."},{"key":"491_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1003431122334","volume":"31","author":"IM Kvetnoy","year":"1999","unstructured":"Kvetnoy, I. M. Extrapineal melatonin: location and role within diffuse neuroendocrine system. Histochem. J. 31, 1\u201312 (1999).","journal-title":"Histochem. J."},{"key":"491_CR13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/molehr\/5.5.402","volume":"5","author":"MT Itoh","year":"1999","unstructured":"Itoh, M. T., Ishizuka, B., Kuribayashi, Y., Amemiya, A. & Sumi, Y. Melatonin, its precursors, and synthesizing enzyme activities in the human ovary. Mol. Hum. Reprod. 5, 402\u2013408 (1999).","journal-title":"Mol. Hum. Reprod."},{"key":"491_CR14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1210\/jcem-64-4-865","volume":"64","author":"A Brzezinski","year":"1987","unstructured":"Brzezinski, A., Seibel, M. M., Lynch, H. J., Deng, M. H. & Wurtman, R. J. Melatonin in human preovulatory follicular fluid. J. Clin. Endocrinol. Metab. 64, 865\u2013867 (1987).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR15","volume":"17","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Higher melatonin in the follicle fluid and MT2 expression in the granulosa cells contribute to the OHSS occurrence. Reprod. Biol. Endocrinol. 17, 37 (2019).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"491_CR16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/ENDO:27:2:101","volume":"27","author":"ML Dubocovich","year":"2005","unstructured":"Dubocovich, M. L. & Markowska, M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 27, 101\u2013110 (2005).","journal-title":"Endocrine"},{"key":"491_CR17","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1210\/jcem.86.10.7912","volume":"86","author":"MM Woo","year":"2001","unstructured":"Woo, M. M. et al. Direct action of melatonin in human granulosa-luteal cells. J. Clin. Endocrinol. Metab. 86, 4789\u20134797 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000052973","volume":"52","author":"J Bodis","year":"2001","unstructured":"Bodis, J., Koppan, M., Kornya, L., Tinneberg, H. R. & Torok, A. Influence of melatonin on basal and gonadotropin-stimulated progesterone and estradiol secretion of cultured human granulosa cells and in the superfused granulosa cell system. Gynecol. Obstet. Invest. 52, 198\u2013202 (2001).","journal-title":"Gynecol. Obstet. Invest."},{"key":"491_CR19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/humrep\/10.1.50","volume":"10","author":"SM Yie","year":"1995","unstructured":"Yie, S. M. et al. Melatonin and steroids in human pre-ovulatory follicular fluid: seasonal variations and granulosa cell steroid production. Hum. Reprod. 10, 50\u201355 (1995).","journal-title":"Hum. Reprod."},{"key":"491_CR20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-079X.1994.tb00121.x","volume":"17","author":"AV Sirotkin","year":"1994","unstructured":"Sirotkin, A. V. Direct influence of melatonin on steroid, nonapeptide hormones, and cyclic nucleotide secretion by granulosa cells isolated from porcine ovaries. J. Pineal Res. 17, 112\u2013117 (1994).","journal-title":"J. Pineal Res."},{"key":"491_CR21","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/humrep\/dez171","volume":"34","author":"L Fang","year":"2019","unstructured":"Fang, L. et al. Human chorionic gonadotropin-induced amphiregulin stimulates aromatase expression in human granulosa-lutein cells: a mechanism for estradiol production in the luteal phase. Hum. Reprod. 34, 2018\u20132026 (2019).","journal-title":"Hum. Reprod."},{"key":"491_CR22","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s12276-020-0396-y","volume":"52","author":"L Fang","year":"2020","unstructured":"Fang, L. et al. TGF-beta1 induces VEGF expression in human granulosa-lutein cells: a potential mechanism for the pathogenesis of ovarian hyperstimulation syndrome. Exp. Mol. Med. 52, 450\u2013460 (2020).","journal-title":"Exp. Mol. Med."},{"key":"491_CR23","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.18632\/aging.102367","volume":"11","author":"L Fang","year":"2019","unstructured":"Fang, L. et al. Melatonin induces progesterone production in human granulosa-lutein cells through upregulation of StAR expression. Aging 11, 9013\u20139024 (2019).","journal-title":"Aging"},{"key":"491_CR24","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/bjp.2008.184","volume":"154","author":"R Jockers","year":"2008","unstructured":"Jockers, R., Maurice, P., Boutin, J. A. & Delagrange, P. Melatonin receptors, heterodimerization, signal transduction and binding sites: what\u2019s new? Br. J. Pharmacol. 154, 1182\u20131195 (2008).","journal-title":"Br. J. Pharmacol."},{"key":"491_CR25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0303-7207(97)00178-0","volume":"134","author":"MD Michael","year":"1997","unstructured":"Michael, M. D., Michael, L. F. & Simpson, E. R. A CRE-like sequence that binds CREB and contributes to cAMP-dependent regulation of the proximal promoter of the human aromatase P450 (CYP19) gene. Mol. Cell. Endocrinol. 134, 147\u2013156 (1997).","journal-title":"Mol. Cell. Endocrinol."},{"key":"491_CR26","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.fertnstert.2008.08.129","volume":"92","author":"O Fainaru","year":"2009","unstructured":"Fainaru, O., Hornstein, M. D. & Folkman, J. Doxycycline inhibits vascular leakage and prevents ovarian hyperstimulation syndrome in a murine model. Fertil. Steril. 92, 1701\u20131705 (2009).","journal-title":"Fertil. Steril."},{"key":"491_CR27","doi-asserted-by":"crossref","first-page":"E258","DOI":"10.1210\/jc.2012-3037","volume":"98","author":"D Chuderland","year":"2013","unstructured":"Chuderland, D. et al. The role of pigment epithelium-derived factor in the pathophysiology and treatment of ovarian hyperstimulation syndrome in mice. J. Clin. Endocrinol. Metab. 98, E258\u2013E266 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR28","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s00018-012-1161-8","volume":"70","author":"S Proietti","year":"2013","unstructured":"Proietti, S., Cucina, A., Reiter, R. J. & Bizzarri, M. Molecular mechanisms of melatonin\u2019s inhibitory actions on breast cancers. Cell. Mol. life Sci. 70, 2139\u20132157 (2013).","journal-title":"Cell. Mol. life Sci."},{"key":"491_CR29","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/JME-15-0310","volume":"57","author":"H Zhao","year":"2016","unstructured":"Zhao, H., Zhou, L., Shangguan, A. J. & Bulun, S. E. Aromatase expression and regulation in breast and endometrial cancer. J. Mol. Endocrinol. 57, R19\u2013R33 (2016).","journal-title":"J. Mol. Endocrinol."},{"key":"491_CR30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.2004-0020","volume":"26","author":"ER Simpson","year":"2005","unstructured":"Simpson, E. R. et al. Estrogen-the good, the bad, and the unexpected. Endocr. Rev. 26, 322\u2013330 (2005).","journal-title":"Endocr. Rev."},{"key":"491_CR31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canlet.2008.05.038","volume":"273","author":"D Chen","year":"2009","unstructured":"Chen, D. et al. Regulation of breast cancer-associated aromatase promoters. Cancer Lett. 273, 15\u201327 (2009).","journal-title":"Cancer Lett."},{"key":"491_CR32","first-page":"292","volume":"11","author":"DL Carlone","year":"1997","unstructured":"Carlone, D. L. & Richards, J. S. Functional interactions, phosphorylation, and levels of 3\u2019,5\u2019-cyclic adenosine monophosphate-regulatory element binding protein and steroidogenic factor-1 mediate hormone-regulated and constitutive expression of aromatase in gonadal cells. Mol. Endocrinol. 11, 292\u2013304 (1997).","journal-title":"Mol. Endocrinol."},{"key":"491_CR33","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1210\/endo.137.8.8754745","volume":"137","author":"A Mukherjee","year":"1996","unstructured":"Mukherjee, A., Park-Sarge, O. K. & Mayo, K. E. Gonadotropins induce rapid phosphorylation of the 3\u2019,5\u2019-cyclic adenosine monophosphate response element binding protein in ovarian granulosa cells. Endocrinology 137, 3234\u20133245 (1996).","journal-title":"Endocrinology"},{"key":"491_CR34","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1210\/mend.13.8.0329","volume":"13","author":"JP Somers","year":"1999","unstructured":"Somers, J. P., DeLoia, J. A. & Zeleznik, A. J. Adenovirus-directed expression of a nonphosphorylatable mutant of CREB (cAMP response element-binding protein) adversely affects the survival, but not the differentiation, of rat granulosa cells. Mol. Endocrinol. 13, 1364\u20131372 (1999).","journal-title":"Mol. Endocrinol."},{"key":"491_CR35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3390\/molecules23040737","volume":"23","author":"JY Sung","year":"2018","unstructured":"Sung, J. Y., Bae, J. H., Lee, J. H., Kim, Y. N. & Kim, D. K. The melatonin signaling pathway in a long-term memory in vitro study. Molecules 23, 737 (2018).","journal-title":"Molecules"},{"key":"491_CR36","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/me.2014-1293","volume":"29","author":"S Costes","year":"2015","unstructured":"Costes, S., Boss, M., Thomas, A. P. & Matveyenko, A. V. Activation of melatonin signaling promotes beta-cell survival and function. Mol. Endocrinol. 29, 682\u2013692 (2015).","journal-title":"Mol. Endocrinol."},{"key":"491_CR37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1023\/A:1024038632570","volume":"79","author":"M Sofi","year":"2003","unstructured":"Sofi, M., Young, M. J., Papamakarios, T., Simpson, E. R. & Clyne, C. D. Role of CRE-binding protein (CREB) in aromatase expression in breast adipose. Breast Cancer Res. Treat. 79, 399\u2013407 (2003).","journal-title":"Breast Cancer Res. Treat."},{"key":"491_CR38","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.fertnstert.2019.05.004","volume":"112","author":"CC Huang","year":"2019","unstructured":"Huang, C. C. et al. Hyperactive CREB signaling pathway involved in the pathogenesis of polycystic ovarian syndrome revealed by patient-specific induced pluripotent stem cell modeling. Fertil. Steril. 112, 594\u2013607 e512 (2019).","journal-title":"Fertil. Steril."},{"key":"491_CR39","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1093\/oxfordjournals.humrep.a135867","volume":"10","author":"G Sher","year":"1995","unstructured":"Sher, G., Zouves, C., Feinman, M. & Maassarani, G. \u2018Prolonged coasting\u2019: an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Hum. Reprod. 10, 3107\u20133109 (1995).","journal-title":"Hum. Reprod."},{"key":"491_CR40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(94)93001-5","volume":"344","author":"N McClure","year":"1994","unstructured":"McClure, N. et al. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 344, 235\u2013236 (1994).","journal-title":"Lancet"},{"key":"491_CR41","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1210\/me.2005-0114","volume":"19","author":"LC Ajonuma","year":"2005","unstructured":"Ajonuma, L. C. et al. Estrogen-induced abnormally high cystic fibrosis transmembrane conductance regulator expression results in ovarian hyperstimulation syndrome. Mol. Endocrinol. 19, 3038\u20133044 (2005).","journal-title":"Mol. Endocrinol."},{"key":"491_CR42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00018-016-2391-y","volume":"74","author":"V Saint-Criq","year":"2017","unstructured":"Saint-Criq, V. & Gray, M. A. Role of CFTR in epithelial physiology. Cell. Mol. life Sci. 74, 93\u2013115 (2017).","journal-title":"Cell. Mol. life Sci."},{"key":"491_CR43","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/humrep\/12.6.1129","volume":"12","author":"U Elchalal","year":"1997","unstructured":"Elchalal, U. & Schenker, J. G. The pathophysiology of ovarian hyperstimulation syndrome-views and ideas. Hum. Reprod. 12, 1129\u20131137 (1997).","journal-title":"Hum. Reprod."},{"key":"491_CR44","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1210\/jc.2011-1363","volume":"97","author":"H Chen","year":"2012","unstructured":"Chen, H. et al. Impaired CFTR-dependent amplification of FSH-stimulated estrogen production in cystic fibrosis and PCOS. J. Clin. Endocrinol. Metab. 97, 923\u2013932 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR45","first-page":"127","volume":"6","author":"A Carocci","year":"2014","unstructured":"Carocci, A., Catalano, A. & Sinicropi, M. S. Melatonergic drugs in development. Clin. Pharmacol. 6, 127\u2013137 (2014).","journal-title":"Clin. Pharmacol."},{"key":"491_CR46","doi-asserted-by":"crossref","first-page":"39896","DOI":"10.18632\/oncotarget.16379","volume":"8","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Melatonin for the prevention and treatment of cancer. Oncotarget 8, 39896\u201339921 (2017).","journal-title":"Oncotarget"},{"key":"491_CR47","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-079X.2004.00152.x","volume":"37","author":"XM Li","year":"2004","unstructured":"Li, X. M., Beau, J., Delagrange, P., Mocaer, E. & Levi, F. Circadian rhythm entrainment with melatonin, melatonin receptor antagonist S22153 or their combination in mice exposed to constant light. J. Pineal Res. 37, 176\u2013184 (2004).","journal-title":"J. Pineal Res."},{"key":"491_CR48","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1600-079X.2005.00233.x","volume":"39","author":"IC Sumaya","year":"2005","unstructured":"Sumaya, I. C., Masana, M. I. & Dubocovich, M. L. The antidepressant-like effect of the melatonin receptor ligand luzindole in mice during forced swimming requires expression of MT2 but not MT1 melatonin receptors. J. Pineal Res. 39, 170\u2013177 (2005).","journal-title":"J. Pineal Res."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00491-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00491-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00491-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T19:16:50Z","timestamp":1630005410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00491-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["491"],"URL":"https:\/\/doi.org\/10.1038\/s12276-020-00491-w","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"26 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}